Evidence map›Paper›PMID 40813920›Full record

ArticleNature metabolism2025

Species-specific serine metabolism differentially controls natural killer cell functions.

Joey H Li, Qinyan Feng, Andréa B Ball, Cassidy D Lee, Michelle L Wallerius, Jan G Bormin, Edmund D Kapelczak, Wesley R Armstrong, Leen Hermans, Abigail Krall and 5 more

Abstract read
In one paragraph

Article in Nature metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. A Role for Astrocyte Metabolism in Species-Specific Neuronal Development.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Joey H LiDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-3865-5876
Qinyan FengDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Andréa B BallDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-8214-7190
Cassidy D LeeDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Michelle L WalleriusDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Jan G BorminDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Edmund D KapelczakDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Wesley R ArmstrongDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Leen HermansDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Abigail KrallDepartment of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Nedas MatulionisDepartment of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-7624-3090
Tara TeSlaaDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-0504-0998
Heather R ChristofkDepartment of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-8662-4425
Ajit S DivakaruniDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-2528-9651
Timothy E O'SullivanDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. tosullivan@mednet.ucla.edu.ORCID http://orcid.org/0000-0003-1435-8188

Funding

Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
MULTIDISCIPLINARY TRAINING IN MICROBIAL PATHOGENESIST32AI007323 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Peter John Bradley · 1988 to 2026
$8.6M
UCLA-Caltech Medical Scientist Training ProgramT32GM152342 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Olujimi A Ajijola, David Wayne Dawson · 2024 to 2026
$5.3M
Nutrient Regulation of Cancer Cell GrowthR01CA215185 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Heather Christofk · 2018 to 2026
$4.3M
Sex Differences in NK Cells Mediated by X-linked UTXR01AI174519 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Timothy E O'Sullivan, Maureen A Su · 2023 to 2026
$2.9M
Understanding How Metabolic Cofactors Control Cell Function and FateR35GM138003 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Ajit Divakaruni · 2020 to 2026
$2.8M
Chemistry Biology Interface Training ProgramT32GM136614 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Patrick G. Harran · 2020 to 2026
$2.8M
Transcriptional mechanisms of natural killer cell responses during mouse cytomegalovirus infectionR01AI145997 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI O'SULLIVAN, TIMOTHY E · 2019 to 2023
$2.3M
Metabolic Control of Hair Follicle Stem Cell Homeostasis and TumorigenesisR01AR070245 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHRISTOFK, HEATHER, LOWRY, WILLIAM E · 2018 to 2022
$2.1M
Transcriptional Regulation of human natural killer cell functionR01AI186079 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Timothy E O'Sullivan · 2025 to 2026
$1.3M
Agilent Technologies 4814NCI NIH HHS R01 CA215185NCI NIH HHS UH2 CA286583NIAID NIH HHS F30 AI181449NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI145997NIAID NIH HHS R01 AI174519NIAID NIH HHS R01 AI186079NIAID NIH HHS T32 AI007323NIAMS NIH HHS R01 AR070245NIDDK NIH HHS P30 DK063491NIGMS NIH HHS R35 GM138003NIGMS NIH HHS T32 GM008042NIGMS NIH HHS T32 GM136614NIGMS NIH HHS T32 GM152342U.S. Department of Health & Human Services | National Institutes of Health (NIH) 2R01AR070245U.S. Department of Health & Human Services | National Institutes of Health (NIH) 2R01CA215185U.S. Department of Health & Human Services | National Institutes of Health (NIH) F30AI181449U.S. Department of Health & Human Services | National Institutes of Health (NIH) P30DK063491U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI145997U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI174519U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM138003U.S. Department of Health & Human Services | National Institutes of Health (NIH) T32AI007323U.S. Department of Health & Human Services | National Institutes of Health (NIH) T32GM136614U.S. Department of Health & Human Services | National Institutes of Health (NIH) T32GM152342U.S. Department of Health & Human Services | National Institutes of Health (NIH) UH2CA286583W. M. Keck Foundation (W.M. Keck Foundation) 995337
6 · The paper itself

Abstract

Immune cells undergo rapid metabolic reprogramming to fuel effector responses. However, whether the metabolic pathways that supply these functions differ between human and mouse immune cells is poorly understood. Using a comparative metabolomics approach, here we show both conserved and species-distinct metabolite alterations in cytokine-activated primary human and mouse natural killer (NK) cells. Activated human NK cells fail to perform de novo serine synthesis, resulting in broadly impaired effector functions when serine starved ex vivo or during in vivo dietary serine restriction, limiting their antitumour function. In contrast, activated mouse NK cells perform de novo serine synthesis to fuel one-carbon metabolism and proliferation, resulting in increased metabolic flexibility during ex vivo and dietary serine restriction. While NK cells from both species require one-carbon metabolism to proliferate and produce interferon-γ, GCLC-dependent glutathione synthesis tunes cytotoxic versus inflammatory function in human NK cells. Thus, activated NK cell functions display species-specific requirements for serine metabolism, and environmental serine availability dictates activated human NK cell functions.

Indexed as

Killer Cells, NaturalSerineAnimalsCell ProliferationHumansMetabolomicsMiceMice, Inbred C57BLSpecies SpecificitySerine

Identifiers

PMID40813920
PMCPMC12861115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.